Balance Sheet for Ligand Pharmaceuticals Incorporated (LGND)

$ 111.64   -0.27 (-0.24%) Volume: 351.01k 4:00 PM EDT 2-Jul-2020
After Hours:  $ 111.64 0.00 (0.00%) Volume: 33.59k 4:50 PM EDT 2-Jul-2020
Statement: View:
Assets [+] in Millions of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 72 117 21 19 97
Restrictable Cash - 3 - - 1
Marketable Securities 998 657 181 122 103
Accounts Receivable 30 56 26 15 6
Loans Receivable - - - - -
Other Receivables - - 0 0 1
Receivables 42 56 29 18 12
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other 7 7 4 2 2
Inventories, Adjustments & Allowances - - - - -
Inventories 7 7 4 2 2
Prepaid Expenses - - 1 2 1
Current Deferred Income Taxes - - - - 8
Other Current Assets 5 11 2 2 3
Total Current Assets 1,124 871 237 163 215
Land and Improvements - - - - -
Buildings and Improvement 3 2 2 2 0
Machinery, Furniture and Equipment 7 5 4 2 3
Construction in Progress - - - - -
Fixed Assets, Other 10 - - - -
Fixed Assets, Total 20 8 6 3 3
Gross Fixed Assets 20 8 6 3 3
Accumulated Depreciation (3) (2) (2) (2) (3)
Net Fixed Assets 18 5 4 2 0
Intangibles 231 251 248 231 57
Cost in Excess 95 87 86 72 12
Non-Current Deferred Income Taxes 26 47 84 124 189
Other Non-Current Assets 2 0 5 2 0
Total Non-Current Assets 371 390 434 439 288
Total Assets 1,495 1,261 671 602 503
Liabilities [+] in Millions of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable (176) 4 2 3 4
Short Term Debt 1 26 225 213 202
Notes Payable - - - - -
Accrued Expenses 4 12 3 4 4
Accrued Liabilities 4 12 3 4 4
Deferred Revenues 2 3 - - 0
Current Deferred Income Taxes 75 30 45 11 (220)
Other Current Liabilities 186 37 9 8 13
Total Current Liabilities 17 82 239 227 223
Long Term Debt 639 610 19 30 40
Deferred Income Tax 33 - 4 0 6
Other Non-Current Liabilities 29 8 14 4 (3)
Minority Interest - - - - -
Capital Lease Obligations 10 - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 711 618 32 33 43
Total Liabilities 728 700 271 260 266
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 767 561 400 341 237
Common Par 0 0 0 0 0
Additional Paid in Capital 367 791 798 770 662
Cumulative Translation Adjustments - - - - -
Retained Earnings 400 (229) (401) (431) (429)
Treasury Stock - - - - -
Other Equity Adjustments (0) (1) 2 3 5
Total Capitalization 1,406 1,171 419 371 277
Total Equity 767 561 400 341 237
Total Liabilities & Shareholder's Equity 1,495 1,261 671 602 503
Cash Flow 596 134 1 (13) 255
Working Capital 1,107 788 (2) (64) (8)
Free Cash Flow (32) 183 86 35 31
Invested Capital 1,406 1,171 419 371 277
Shares Outstanding - Common Class Only 17 21 21 21 20
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 17 21 21 21 20
Total Common Shares Outstanding 17 21 21 21 20
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 19 21 21 21 20
Diluted Weighted Shares Outstanding 20 24 23 21 21